{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:25:59Z","timestamp":1768004759262,"version":"3.49.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/03007995.2022.2059977","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:01:11Z","timestamp":1648735271000},"page":"1167-1176","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets"],"prefix":"10.1080","volume":"38","author":[{"given":"Helmut","family":"Butzkueven","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia"},{"name":"The Alfred Hospital, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[{"name":"Bordeaux PharmacoEpi (BPE), Universit\u00e9 de Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Global Biostatistics, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA (an affiliate of Merck KGaA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaak","family":"S\u00f5najalg","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Bezemer","sequence":"additional","affiliation":[{"name":"Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi","family":"Korhonen","sequence":"additional","affiliation":[{"name":"IQVIA (former EPID Research), Espoo, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Sabid\u00f3","sequence":"additional","affiliation":[{"name":"Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the CLARION Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01667-7"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322326"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1658741"},{"key":"CIT0004","unstructured":"European Medicines Agency. Use of disease registries for benefit-risk evaluation of medicines: a regulatory perspective 2018. Available from: www.ema.europa.eu\/en\/documents\/presentation\/presentation-registry-initiative-april-2018_en.pdf."},{"issue":"2","key":"CIT0005","first-page":"761","volume":"25","author":"Hillert J","year":"2019","journal-title":"Mult Scler"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.02.018"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.038"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419854986"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.021"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102572"},{"key":"CIT0011","unstructured":"European Medicines Agency. Guideline on Risk Management Systems for Medicinal Products for Human Use [EMEA\/CHMP\/96268\/2005] 2005. [Feb 2021]. Available from: https:\/\/www.pharmacoepi.org\/pub\/?id=1c2a4382-2354-d714-51bd-b9fdecdb3d0c."},{"key":"CIT0012","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance registration number, EUPAS24484 Available from: www.encepp.eu\/encepp\/viewResource.htm?id=28797."},{"issue":"2","key":"CIT0013","first-page":"622","volume":"27","author":"Hillert J","year":"2021","journal-title":"Mult Scler"},{"issue":"15","key":"CIT0014","first-page":"P4.2","volume":"92","author":"Wormser D","year":"2019","journal-title":"Neurology"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514528760"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12427"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12425"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09238-8"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1407039"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.02.017"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1177\/1403494817702336"},{"key":"CIT0022","author":"Magyari M","year":"2021","journal-title":"ICPE"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70005-5"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1177\/2055217317732802"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000477"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517727603"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00489"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103490"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1002\/9780470059876"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2022.2059977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:47:00Z","timestamp":1657028820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2022.2059977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/03007995.2022.2059977"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2022.2059977","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}